Oncology & Cancer

New research may aid treatment of multiple myeloma patients

A study led by Robert G. Hawley, Ph.D., professor and chair of the department of anatomy and regenerative biology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), may help predict which ...

Oncology & Cancer

AACR: tumor vulnerability varies with clonal evolution in ALL

(HealthDay)—In acute lymphoblastic leukemia (ALL), tumor vulnerability to different chemotherapeutic agents varies at different stages of clonal evolution, which could represent a viable strategy in avoiding drug resistance. ...

Oncology & Cancer

Neurotoxicity of chemotherapy drugs

Chemotherapy is one of the primary treatments for cancer. However, one of the most disturbing findings of recent studies of cancer survivors is the apparent prevalence of chemotherapy-associated adverse neurological effects, ...

Oncology & Cancer

Cancer therapy: Nanokey opens tumors to attack

There are plenty of effective anticancer agents around. The problem is that, very often, they cannot gain access to all the cells in solid tumors. A new gene delivery vehicle may provide a way of making tracks to the heart ...

page 9 from 12